Literature DB >> 3293835

PET in clinical oncology.

R A Hawkins1, M E Phelps.   

Abstract

Positron Emission Tomography (PET) is an imaging technique that produces cross sectional images based on tissue biochemical and physiological processes. PET complements other anatomic imaging techniques such as x-ray CT and magnetic resonance imaging (MRI). Fundamental processes such as glucose metabolism, oxygen metabolism, and blood flow can be imaged and quantified with PET, in addition to many other processes of both clinical and investigative interest. PET is now emerging as a clinical tool in oncology and is useful in noninvasively grading tumors, in determining tumor activity and recurrence, and in monitoring the effects of a variety of therapeutic interventions with tumors. While most of the applications of PET in oncology to date have been in brain tumors, the technique is now being applied in tumor evaluations outside of the central nervous system.

Entities:  

Mesh:

Year:  1988        PMID: 3293835     DOI: 10.1007/bf00046482

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  83 in total

1.  Design and performance characteristics of a whole-body positron transaxial tomograph.

Authors:  E J Hoffmann; M E Phelps; N A Mullani; C S Higgins; M M Ter-Pogossian
Journal:  J Nucl Med       Date:  1976-06       Impact factor: 10.057

2.  Emission computed tomography.

Authors:  M E Phelps
Journal:  Semin Nucl Med       Date:  1977-10       Impact factor: 4.446

Review 3.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

Review 4.  Positron emission tomography in the study of human tumors.

Authors:  R P Beaney
Journal:  Semin Nucl Med       Date:  1984-10       Impact factor: 4.446

5.  Measurement of brain pH using 11CO2 and positron emission tomography.

Authors:  R B Buxton; L R Wechsler; N M Alpert; R H Ackerman; D R Elmaleh; J A Correia
Journal:  J Cereb Blood Flow Metab       Date:  1984-03       Impact factor: 6.200

6.  Brain tumor evaluation using Rb-82 and positron emission tomography.

Authors:  C K Yen; Y Yano; T F Budinger; R P Friedland; S E Derenzo; R H Huesman; H A O'Brien
Journal:  J Nucl Med       Date:  1982-06       Impact factor: 10.057

7.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

8.  Selection of experimental conditions for the accurate determination of blood--brain transfer constants from single-time experiments: a theoretical analysis.

Authors:  R G Blasberg; C S Patlak; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-06       Impact factor: 6.200

9.  Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-Methionine.

Authors:  P Bustany; M Chatel; J M Derlon; F Darcel; P Sgouropoulos; F Soussaline; A Syrota
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

Review 10.  Positron computed tomography for studies of myocardial and cerebral function.

Authors:  M E Phelps; H R Schelbert; J C Mazziotta
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

View more
  14 in total

1.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.

Authors:  John M Floberg; Julie K Schwarz
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 3.  Famine versus feast: understanding the metabolism of tumors in vivo.

Authors:  Jared R Mayers; Matthew G Vander Heiden
Journal:  Trends Biochem Sci       Date:  2015-01-29       Impact factor: 13.807

4.  Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

Authors:  Joanna Zawacka-Pankau; Vera V Grinkevich; Sabine Hünten; Fedor Nikulenkov; Angela Gluch; Hai Li; Martin Enge; Alexander Kel; Galina Selivanova
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

Review 5.  Manipulating extracellular tumour pH: an effective target for cancer therapy.

Authors:  Guanyu Hao; Zhi Ping Xu; Li Li
Journal:  RSC Adv       Date:  2018-06-19       Impact factor: 4.036

6.  Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging.

Authors:  W Mueller-Klieser; S Walenta
Journal:  Histochem J       Date:  1993-06

Review 7.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02

8.  A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2007-11-04       Impact factor: 2.691

Review 9.  Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

10.  Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points.

Authors:  E K Rofstad; K Måseide
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.